SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Treatment hope for cognitive symptoms in Parkinson's disease
Tues May 17th - Ultra-powerful 7T MRI scanners could help to identify those patients with conditions such as Parkinson's disease who would benefit from new treatments for cognitive symptoms that were previously untreatable, British researchers report today. More
E-cigarettes as effective as patches for pregnant women
Tues May 17th - E-cigarettes can help pregnant women to stop smoking and are as safe as nicotine patches, according to new UK research. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
Pharmaceuticals

Pharmaceuticals

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64

14/07/2021 - Plasma jabs no use for Achilles pain
A new study has found no benefit for treatment with platelet rich plasma injections for Achilles tendinopathy. More

12/07/2021 - Flu vaccines, HIV risks and double infection reported to conference
People vaccinated against flu may have enjoyed some protection against the worst effects of COVID-19, a major European conference has heard. More

09/07/2021 - Children's risk of developing severe COVID-19 'very low'
The risk of severe illness and death from COVID-19 is extremely low in children and teenagers, according to the most comprehensive analyses of public health data yet. More

08/07/2021 - Aspirin reduces heart attack risk in pneumonia patients
Aspirin can reduce the risk of myocardial infarction and stroke in patients with pneumonia, a new study reveals today. More

08/07/2021 - Back pain drugs and orthopaedic procedures questioned
Prescribing muscle relaxant drugs for low back pain gives only short-term relief and there is an increased risk of side-effects, new analysis claims today. More

07/07/2021 - Immune drug brings overall benefit for COVID-19
Mortality among patients hospitalised with COVID-19 is reduced when they receive treatment with Interleukin-6 antagonists, according to the findings of a major analysis that has led to a change to global guidelines. More

06/07/2021 - Aspirin could reduce metastatic spread
Aspirin could cut the risk of death in some cancer patients by up to 20%, according to a new analysis. More

06/07/2021 - Novel HIV vaccine trial starts at Oxford
A phase I trial into a novel HIV vaccine has begun in the UK. More

02/07/2021 - New warning on Africa pandemic
Africa is suffering from a “surging” third wave of the pandemic caused by several new variants, the World Health Organisation warned yesterday. More

30/06/2021 - Novel pancreatic cancer biomarker found
A new biomarker for pancreatic cancer has been identified, raising hopes of earlier diagnosis, British researchers have announced. More

29/06/2021 - Vaccine variations pass tests
Delaying second vaccine doses for months and mixing different types of COVID-19 vaccine all seem to be effective, according to findings reported by British researchers. More

28/06/2021 - Booster vaccine targets rogue variant
The first vaccine specifically tailored to tackle a new variant of COVID-19 is now being tested on volunteers, it was announced last night. More

23/06/2021 - Statins for heart failure linked to fewer cancers
People with heart failure who take statins may be at a reduced risk of cancer, researchers say today. More

23/06/2021 - Test may protect bladder cancer patients from relapse
Researchers looking at a new biomarker of residual bladder cancer have found that it identifies high risk patients who may benefit from additional treatment. More

18/06/2021 - Promising new way to fight SARS-CoV-2 unveiled
A new treatment that mends cell damage, rather than fighting the SARS-CoV-2 virus, has been shown to be effective in lab models. More

18/06/2021 - New drug class for cancers with faulty BRCA genes
A new class of targeted cancer drugs could treat patients whose tumours have faulty copies of the BRCA cancer genes, British researchers have reported. More

17/06/2021 - Monoclonal antibody combination can save COVID-19 patients' lives
An antibody combination reduces the number of deaths among patients hospitalised with severe COVID-19 when they are are unable to mount their own immune response, British researchers have announced. More

16/06/2021 - Needle phobia partly explains vaccine refusal
People with needle phobia are twice as likely to delay or refuse a COVID-19 vaccine as others, British researchers report today. More

16/06/2021 - Cold virus may limit COVID-19
Viruses which cause the common cold may protect against COVID-19, new research suggests. More

15/06/2021 - Could semaglutide protect people with type 2 diabetes?
A major new study will assess if a daily dose of semaglutide could help to prevent people with type 2 diabetes developing cardiovascular disease, it has been announced. More

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64

Printer friendly page Printer friendly page

CATEGORIES